Retrospective evaluation of the predictive value of tumour burden at baseline [ 68 Ga]Ga-DOTA-TOC or -TATE PET/CT and tumour dosimetry in GEP-NET patients treated with PRRT.
Anni GålneAnna SundlövOlof EnqvistKatarina Sjögreen GleisnerErik LarssonElin TrägårdhPublished in: EJNMMI reports (2024)
Tumour burden at baseline showed no predictive value of PFS/OS after PRRT in this small retrospective study. An increase of tumour burden was predictive of worse outcome.